Clinicopathologic features and genetic characteristics of the BRCA1/2 mutation in Turkish breast cancer patients

ÇEÇENER G., Takanlou L. S., Takanlou M. S., EGELİ Ü., Eskiler G. G., AKSOY S., ...Daha Fazla

CANCER GENETICS, cilt.240, ss.23-32, 2020 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 240
  • Basım Tarihi: 2020
  • Doi Numarası: 10.1016/j.cancergen.2019.10.004
  • Dergi Adı: CANCER GENETICS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database
  • Sayfa Sayıları: ss.23-32
  • Anahtar Kelimeler: Breast cancer, BRCA1, BRCA2, Pathogenic mutations, Variant of uncertain significance, OVARIAN-CANCER, GERMLINE MUTATIONS, TUMOR CHARACTERISTICS, PHYSICAL-ACTIVITY, RISK, POPULATION, PREVALENCE, WOMEN, ASSOCIATIONS, VARIANTS
  • Bursa Uludağ Üniversitesi Adresli: Evet

Özet

The aim of this study was to identify the frequency and spectrum of germline BRCA1/2 pathogenic alterations in a cohort of patients with breast carcinoma. In this study, a total of 603 breast cancer subjects from Turkey were screened for BRCA1/BRCA2 mutations using HDA and Sanger sequencing. In the present study, 21 BRCA1 and BRCA2 pathogenic variants were detected in 30 patients and BRCA1/2 mutations were significantly associated with a family history of breast/ovarian cancer. Analysis of overall survival for BRCA1/BRCA2 mutation carriers showed a trend for poor overall survival only in BRCA1 carriers, although this was not statistically significant in BRCA1 and BRCA2 mutation carriers. The c.5266dupC mutation is one of the most frequently reported mutations in BRCA1 and was identified in five breast cancer patients in our study. The most common BRCA2 gene mutations in the present study were c.8940delA and c.9097dupA, which were found in seven patients. We found mostly BRCA1 and BRCA2 mutation carriers in those patients who showed hormone-positive features. In conclusion, our data showed differences in the distribution of the mutation spectrum of BRCA1 and BRCA2 in Turkey. (C) 2019 Elsevier Inc. All rights reserved.